Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Triazolam
Drug ID BADD_D02277
Description Withdrawn in the United Kingdom due to risk of psychiatric adverse drug reactions. This drug continues to be available in the U.S. Internationally, triazolam is a Schedule IV drug under the Convention on Psychotropic Substances.
Indications and Usage For the short-term treatment of insomnia.
Marketing Status Prescription; Discontinued
ATC Code N05CD05
DrugBank ID DB00897
KEGG ID D00387
MeSH ID D014229
PubChem ID 5556
TTD Drug ID D0U3LS
NDC Product Code 0009-0017; 55289-787; 67763-128; 0054-4858; 0009-5188; 50742-645; 59762-3718; 50742-646; 71335-1876; 59762-3717; 50090-4733; 12828-0041; 0054-4859; 43063-996; 50090-0522; 42816-0017; 43353-451; 63629-2956
Synonyms Triazolam | U-33,030 | U 33,030 | U33,030 | Halcion | Trilam | Apo-Triazo | Apo Triazo | Gen-Triazolam | Gen Triazolam
Chemical Information
Molecular Formula C17H12Cl2N4
CAS Registry Number 28911-01-5
SMILES CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Coma17.02.09.0010.004616%Not Available
Completed suicide19.12.01.001; 08.04.01.0100.001927%Not Available
Confusional state19.13.01.001; 17.02.03.0050.013849%
Constipation07.02.02.001--
Coordination abnormal17.02.02.004--Not Available
Deafness04.02.01.001--Not Available
Death08.04.01.001--
Decubitus ulcer23.03.11.0060.001847%Not Available
Delirium19.13.02.0010.013849%
Delusion19.10.01.001--
Dementia19.20.02.001; 17.03.01.0010.004616%Not Available
Dependence19.07.02.0030.001847%Not Available
Depressed level of consciousness17.02.04.0020.008310%
Depression19.15.01.001--
Derealisation19.10.02.001--Not Available
Dermatitis23.03.04.002--Not Available
Developmental coordination disorder19.22.01.001; 17.02.02.011--Not Available
Diarrhoea07.02.01.001--
Diplopia17.17.01.005; 06.02.06.0020.003693%Not Available
Discomfort08.01.08.003--Not Available
Disinhibition19.05.01.0020.002770%Not Available
Disorientation19.13.01.002; 17.02.05.0150.005540%Not Available
Disturbance in attention19.21.02.002; 17.03.03.0010.001847%
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.0040.007386%
Drug abuse19.07.02.0100.013970%Not Available
Drug dependence19.07.02.0090.007386%Not Available
Drug hypersensitivity10.01.01.0010.016619%Not Available
Drug withdrawal syndrome19.07.02.011; 08.06.02.0040.000723%Not Available
Drug withdrawal syndrome neonatal19.07.02.012; 18.04.13.001; 08.06.02.0080.001847%Not Available
Dry mouth07.06.01.002--
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 7 Pages